- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03770078
Assessment of New Enhanced Ostomy Device in Real-life Settings in Subjects Having a Stoma
September 1, 2020 updated by: Coloplast A/S
The study investigates the performance of a new adhesive with regard to the skin condition
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
23
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Have given written informed consent
- Have an ileostomy or a colostomy with liquid* output (as their usual output)
- Be at least 18 years of age and have full legal capacity
- Have had their stoma for at least three months
- Be able to use products with max cut size 45 mm
- Have self-reported problems with leakage** (three times within 14 days)
- Handle the Clinical App, test product and comparator product themselves
- Use a flat SenSura® Mio or a flat SenSura® with standard adhesive as their current product
- Minimum change of baseplate at least once every 3rd day
- Are willing and suitable (determined by investigator/study nurse) to use the test product and comparator without using a paste/mouldable ring during the investigation
- Are willing and suitable (determined by investigator/study nurse) to use a 1-piece product during the investigation
Exclusion Criteria:
- Are currently receiving or have within the past two months received radio-and/or chemotherapy (low doses chemotherapy are allowed for other indications than cancer, e.g. below 15 mg methotrexate for rheumatoid arthritis)
- Are currently receiving or have within the past month received topical steroid treatment in the peristomal skin area (e.g. lotion or spray) or systemic treatment* (e.g. injection or tablets).
- Get a positive result of a pregnancy test for women of childbearing age/fertile (**clarified in section 6.3.2)
- Are breast feeding
- Are participating in other interventional clinical investigations or have previously participated in this investigation
Exception:
Participation in other Coloplast in-house clinical investigations is accepted under the circumstances that the subject has paused the activities in the investigation and are otherwise complying with the inclusion and exclusion criteria of this (CP300) protocol.
- Have known hypersensitivity towards any of the products used in the investigation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Study period
First the subjects will use the comparator (SenSura Mio) and then the test products (Test Product A)
|
The test product is a newly developed ostomy product
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Trans Epidermal Water Loss
Time Frame: Four weeks
|
Trans epidermal water loss is an objective skin measurement that is measures the evaporation of water on the skin surface using a probe (DermaLab).The trans epidermal water loss is a measure for the skins barrier function.
There is always aloss of water from the skin due to evaporation.
When the skin barrier is damaged this evaporation of water increases.
Thus, transepidermal water loss can be used to assess skin damage
|
Four weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Birte P Jakobsen, MD, Consultant
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 12, 2018
Primary Completion (Actual)
March 6, 2019
Study Completion (Actual)
March 6, 2019
Study Registration Dates
First Submitted
December 7, 2018
First Submitted That Met QC Criteria
December 7, 2018
First Posted (Actual)
December 10, 2018
Study Record Updates
Last Update Posted (Actual)
September 3, 2020
Last Update Submitted That Met QC Criteria
September 1, 2020
Last Verified
September 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- CP300
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ileostomy - Stoma
-
Chang Gung Memorial HospitalConvaTect, TaiwanUnknownStoma Ileostomy | Stoma ColostomyTaiwan
-
Coloplast A/SCompleted
-
11 Heath and Technologies LimitedThe Cleveland ClinicUnknownIleostomy; Complications | Ileostomy - StomaUnited States
-
Massachusetts General HospitalRecruitingSurgery | Ileostomy - Stoma | Colostomy StomaUnited States
-
BBraun Medical SASRecruitingEnterostomy | Stoma Ileostomy | Stoma ColostomySpain
-
Hospital de BasurtoAlberto Loizate Totoricaguena; Pedro García AlonsoUnknownIleostomy; Complications | Ileostomy - Stoma | Stoma Ileostomy | Ileus ParalyticSpain
-
Coloplast A/SCompleted
-
DHQ mardanDHQ HOSPITAL MARDANCompleted
-
Coloplast A/SIWK Health Centre; Children's National; Driscoll Children's HospitalWithdrawn
-
University of Kansas Medical CenterCompletedStoma IleostomyUnited States
Clinical Trials on Test Product A
-
Coloplast A/SCompletedStoma Site LeakageDenmark
-
Danone ResearchCompleted
-
Coloplast A/SCompletedColostomy Stoma | Ileostomy StomaDenmark
-
Coloplast A/SCompletedColostomy | IleostomyUnited States, United Kingdom, Netherlands, Denmark
-
Coloplast A/SCompleted
-
Boehringer IngelheimCompleted
-
Unilever R&DCompleted
-
GlaxoSmithKlineCompletedDenture RetentionUnited States
-
Coloplast A/SCompletedCompliance, PatientDenmark